Drug data last refreshed 16h ago · AI intelligence enriched 1mo ago
NATAZIA is an oral contraceptive combining estradiol valerate with dienogest in a dynamic dosing regimen designed to mimic the natural menstrual cycle. It is indicated for pregnancy prevention in women of reproductive age. The formulation uses estradiol (a natural estrogen) paired with dienogest (a progestin) to provide contraceptive efficacy while potentially reducing hormone-related side effects.
With 1.3 years until LOE and minimal Part D penetration ($121K), the brand is in defensive mode; teams are likely focused on retention and cost management rather than expansion.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Patent cliff in ~2 years — expect lifecycle management and generic defense hiring
Worked on NATAZIA at Bayer? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Working on NATAZIA offers exposure to the competitive oral contraceptive market and Bayer's women's health franchise, but limited career advancement given the product's approaching LOE and minimal commercial activity. Roles focus on defensive positioning and managed transition rather than growth strategy.
Upgrade to Pro to access patent cliff timelines and LOE dates and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access Medicare Part D spending data and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/mo